700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Review Article Open Access
Pulmonary involvement seems to be a more frequent extraintestinal manifestation of IBD than thus far supposed. In IBD, the respiratory involvement may include a wide range of pathologies. The patients with IBD are in high risk of infections. The drugs used in the treatment of IBD (sulfasalazine, mesalamine, infliximab, and methotrexate) can induce pulmonary diseases as a side effect.
Pulmonary function tests and high resolution CT are useful for detecting subclinical or clinical pulmonary involvement in IBD patients. Pulmonary function tests (PFT) and high-resolution CT (HRCT) showed abnormality in about one-quarter of patients with IBD. Corticosteroids, both systemic and aerosolized, are the main therapeutical approach, while antibiotics must also be administered in infections. Early identification is important as early treatment may improve long-term outcomes in these patients.
To read the full article Peer-reviewed Article PDF
| Peer-reviewed Full Article
Author(s): Ioannis L Triantafyllakis Eftychia Giagkou Zikos Malakos Eleni N Albani Konstantinos H Katsanos Dimitrios K Christodoulou
Inflammatory bowel disease, Extraintestinal manifestations, Crohnâs ulcerative colitis, Drugs, Lungs, Pulmonary infections, Immunosuppressant., Interstitial Lung Disease, Chronic obstructive Lung Disease